Indian companies have come across as innovators in early-stage vaccine development research
Experts have informed Prime Minister Narendra Modi that more than 30 vaccines of the novel coronavirus are in different stages of development and a few are going to trial stages in India.
Indian companies have come across as innovators in early-stage vaccine development research, according to a statement released by the Prime Minister's office after the meeting, reported Hindustan Times.
Prime Minister Modi has chaired a meeting of the task force on coronavirus vaccine development and took a detailed review of the current status of India's steady efforts in vaccine development, drug discovery, diagnosis and testing.
The statement said that three approaches are being taken in drug development in the country.
"First, the repurposing of existing drugs. At least four drugs are undergoing synthesis and examination in this category," the statement said.
"Secondly, the development of new candidate drugs and molecules are being driven by linking high performance computational approached with laboratory verification. Thirdly, plant extracts and products are being examined for general anti-viral properties," it added.
Several academic research institutions and start-ups have developed new tests, both for the Reverse transcription-polymerase chain reaction (RT-PCR) approach and for antibody detection, in diagnosis and testing. Capacity for both these tests has been enormously scaled up by linking laboratories across the country.
"The problem of importing reagents for testing has been addressed by consortia of Indian start-ups and industry, meeting current requirements. The current thrust also holds promise for the development of a robust long-term industry in this area," the statement said.